phrykt

Maravai Lifesciences Holdings, Inc. (MRVI): who owns it and who trades it

As of Nov 16, 2026, MRVI insiders reported 2 open-market sales worth $254K and 2 purchases worth $369K in the last 12 months, with 100% of the sale value made under pre-set 10b5-1 plans. The largest seller was Kurt Oreshack (General Counsel), with $254K. 5 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Maravai Lifesciences Holdings

From the latest filings

Overall: more buying than selling. Famous investors mostly sold. Insiders mostly bought.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Insider trades

In the last 12 months, MRVI insiders reported $369K of open-market purchases and $254K of sales. 100% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$369K
2 trades, 1 people
Sales, 12 months
$254K
2 trades, 1 people
Sales under a 10b5-1 plan
100%
Share of sale value
Latest trade
Jun 10, 2026
Filed Jun 10, 2026

Purchases and sales by month

$369K$369KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Jun 10, 2026Kurt OreshackGeneral CounselSale plan25,000$5.10$127KForm 4
Jun 9, 2026Kurt OreshackGeneral CounselSale plan25,000$5.06$126KForm 4
Dec 8, 2025Gregory T LucierDirectorPurchase48,528$3.67$178KForm 4
Dec 5, 2025Gregory T LucierDirectorPurchase51,472$3.70$190KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Gregory T LucierDirector$369K–Dec 8, 2025
Kurt OreshackGeneral Counsel–$254KJun 10, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

MRVI short interest

14.05M MRVI shares are sold short. Over the last 12 reports the number of shares short went up 65%.

As of Oct 30, 2026, 14.05M MRVI shares were sold short, up 5.3% from the report before. At the average daily volume of 2.06M shares, buying them all back would take about 6.8 trading days (days to cover).

Shares short

14.05MMay 15Oct 3014.98M

Days to cover

6.8May 15Oct 307.6

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202614.05M–+5%2.06M6.8
Oct 15, 202613.35M–-3%3.00M4.5
Sep 30, 202613.83M–+12%2.34M5.9
Sep 15, 202612.37M–+13%2.66M4.7
Aug 31, 202610.96M–+17%6.61M1.7
Aug 14, 20269.38M–+10%2.04M4.6
Jul 31, 20268.51M–-8%2.35M3.6
Jul 15, 20269.27M–+5%3.11M3.0
Jun 30, 20268.81M–+2%3.78M2.3
Jun 15, 20268.65M–+10%2.92M3.0
May 29, 20267.87M–-8%2.67M3.0
May 15, 20268.51M–-4%3.19M2.7

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Maravai Lifesciences Holdings company events

Maravai Lifesciences Holdings filed 5 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Aug 6, 2026.

  1. Aug 6, 2026ResultsReleased financial results. Filing
  2. Jun 3, 2026AgreementMaravai Intermediate Holdings, LLC and Maravai Topco Holdings, LLC, each a consolidated subsidiary controlled by Maravai LifeSciences Holdings, Inc., entered into a Credit Agreement with certain lenders and issuing banks party thereto and BSP Agency, LLC, as administrative agent and collateral agent. Filing
  3. May 29, 2026VoteReported shareholder vote results. Filing
  4. May 7, 2026ResultsReleased financial results. Filing
  5. Feb 25, 2026ResultsReleased financial results. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Maravai Lifesciences Holdings financials

Famous investors that hold MRVI

5 of the 50 well-known investors we track reported holding MRVI in their latest 13F filing. The largest position is Israel Englander's, worth $58.4M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Israel Englander · Millennium ManagementQ3 20267.62M$58.4M0.0%+17%
Jim Simons · Renaissance TechnologiesQ3 20263.99M$30.5M0.0%-13%
Steve Cohen · Point72 Asset ManagementQ3 20262.51M$19.3M0.0%+25%
Ken Griffin · Citadel AdvisorsQ3 20261.86M$14.2M0.0%-12%
Paul Tudor Jones · Tudor Investment CorpQ3 20261.03M$7.9M0.0%-44%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Maravai Lifesciences Holdings, Inc. (MRVI) stock

Are MRVI insiders buying or selling?

In the last 12 months, MRVI insiders reported 2 open-market purchases worth $369K and 2 sales worth $254K. The latest trade was on Jun 10, 2026. See every trade.

What is the short interest in MRVI?

As of Oct 30, 2026, 14.05M MRVI shares were sold short, up 5.3% from the report before. At the average daily volume of 2.06M shares, buying them all back would take about 6.8 trading days (days to cover). See the history.

Which famous investors hold MRVI?

5 of the 50 well-known investors we track reported MRVI in their latest 13F filing, including Israel Englander, Jim Simons, Steve Cohen. The largest position is worth $58.4M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.